Evidence map›Paper›PMID 41341011›Full record

ArticlePatient preference and adherence2025

A Novel Screening Method to Prioritise Cardiovascular Patients Receiving a Pharmaceutical Care Intervention and the Effects on Patients' Difficulties with Managing Their Drug Treatment.

Viktoria Jungreithmayr, Janina A Bittmann, Viktoria S Wurmbach, Miriam Degen, Theresa Dierkes, Sofia Obersteiner, Bastian Bruns, Stephanie Estel, Till Johannes Bugaj, Hanna M Seidling

Abstract read
In one paragraph

Article in Patient preference and adherence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Viktoria JungreithmayrHeidelberg University, Medical Faculty Heidelberg / Heidelberg University Hospital, Internal Medicine IX - Department of Clinical Pharmacology and Pharmacoepidemiology, Cooperation Unit Clinical Pharmacy, Heidelberg, 69120, Germany.ORCID 0000-0003-0620-236X
Janina A BittmannHeidelberg University, Medical Faculty Heidelberg / Heidelberg University Hospital, Internal Medicine IX - Department of Clinical Pharmacology and Pharmacoepidemiology, Cooperation Unit Clinical Pharmacy, Heidelberg, 69120, Germany.ORCID 0009-0006-3893-736X
Viktoria S WurmbachHeidelberg University, Medical Faculty Heidelberg / Heidelberg University Hospital, Internal Medicine IX - Department of Clinical Pharmacology and Pharmacoepidemiology, Cooperation Unit Clinical Pharmacy, Heidelberg, 69120, Germany.
Miriam DegenHeidelberg University, Medical Faculty Heidelberg / Heidelberg University Hospital, Internal Medicine IX - Department of Clinical Pharmacology and Pharmacoepidemiology, Cooperation Unit Clinical Pharmacy, Heidelberg, 69120, Germany.
Theresa DierkesHeidelberg University, Medical Faculty Heidelberg / Heidelberg University Hospital, Internal Medicine IX - Department of Clinical Pharmacology and Pharmacoepidemiology, Cooperation Unit Clinical Pharmacy, Heidelberg, 69120, Germany.
Sofia ObersteinerHeidelberg University, Medical Faculty Heidelberg / Heidelberg University Hospital, Internal Medicine IX - Department of Clinical Pharmacology and Pharmacoepidemiology, Cooperation Unit Clinical Pharmacy, Heidelberg, 69120, Germany.
Bastian BrunsDepartment of General Internal Medicine and Psychosomatics, Heidelberg University Hospital, Heidelberg, 69120, Germany.
Stephanie EstelDepartment of General Internal Medicine and Psychosomatics, Heidelberg University Hospital, Heidelberg, 69120, Germany.
Till Johannes Bugaj *Department of General Internal Medicine and Psychosomatics, Heidelberg University Hospital, Heidelberg, 69120, Germany.
Hanna M Seidling *Heidelberg University, Medical Faculty Heidelberg / Heidelberg University Hospital, Internal Medicine IX - Department of Clinical Pharmacology and Pharmacoepidemiology, Cooperation Unit Clinical Pharmacy, Heidelberg, 69120, Germany.ORCID 0000-0002-1215-634X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Hospitalisation is usually accompanied by changes in patients' drug regimen followed by increased information need. To identify inpatients most suitable for pharmaceutical care interventions addressing these information needs, different prioritisation strategies exist. Here, we present a novel screening method taking particularly patient-reported needs into account. We aimed to test (i) whether the screening method is able to identify patients who benefit most from an intervention, and (ii) whether the intervention can actually reduce patients' difficulties with managing their drug treatment. Patients and Methods: This study comprised of an admission screening, a pharmaceutical care intervention during the inpatient stay, and a follow-up phone call after discharge. During screening, patients answered questionnaires regarding e. g., their beliefs about medicine, adherence, and complexity of drug treatment. According to predefined criteria, patients were selected for the intervention. During intervention, patients received counselling and information leaflets according to their needs. After the inpatient visit, all screened patients were contacted for a follow-up call. During intervention and follow-up, patients were asked applicable key questions on factors potentially increasing complexity of drug treatment to identify difficulties with managing their drug treatment. Results: Among 128 screened patients, 105 were deemed suitable for the intervention. Patients receiving the intervention showed less difficulties with managing their drug treatment after discharge (mean difficulties during intervention = 1.3 vs mean difficulties during follow-up = 0.9, p = 0.040). However, at follow-up, the number of patients' difficulties did not differ between patients suitable or unsuitable for the intervention and between suitable patients receiving or not receiving the intervention (p = 0.434). Conclusion: The novel screening method identified many patients with high information needs, but its effectiveness for prioritisation is limited. While the intervention reduced patients' difficulties with managing drug treatment over time, no significant differences were observed between intervention groups.

Indexed as

difficulties with managing drug treatmentpharmaceutical care interventionscreening methodtertiary care

Identifiers

PMID41341011
PMCPMC12671083

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.